Evolution of the imCORE Network during and post the COVID-19 pandemic: shifting priorities in oncology clinical trials
Site networks positively impacted site knowledge and experience through the pandemic and beyond. Sponsors must recognize each site as a unique entity with their own priorities and focus while understanding a commonality of priorities within regions and among research sites globally. We recommend the creation of site networks to further strengthen the sponsor-site relationship.
Authors
- Sarah Churchill
- Janice Russell (ORCID: https://orcid.org/0000-0003-3690-9980)
- Sarah Helou
- Tanya Vidhyarkorn
- Catherine Scher
- San Tran
Institutions
- Peter MacCallum Cancer Centre (AU)
- Dana-Farber Cancer Institute (US)
- Dallas Nephrology Associates (US)
Publication Details
- Journal
- Future Oncology
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1080/14796694.2025.2520147
- Primary Topic
- Economic and Financial Impacts of Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00